A study led by researchers from MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients.
The National Cancer Institute approved the following clinical research studies last month.
The European Commission has approved Opdivo (nivolumab) for the adjuvant treatment of adult patients with esophageal or gastroesophageal junction cancer who have residual pathologic disease following prior neoadjuvant chemoradiotherapy.
FDA has accepted the Biologics License Application and granted Priority Review for Tecentriq (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer whose tumors express PD-L1≥1%, as determined by an FDA-approved test.
A supplemental New Drug Application for Cabometyx (cabozantinib) was granted FDA priority review as a treatment for patients 12 years and older with differentiated thyroid cancer who have progressed following prior therapy and are radioactive iodine-refractory (if radioactive iodine is appropriate).
Bristol Myers Squibb has withdrawn the U.S. indication for Istodax for relapsed/refractory peripheral T-cell lymphoma.
The vast majority of hospitals in the United States—up to 80%—treat patient populations that are disproportionately white, U.S. News & World Report said, unveiling a new suite of health equity measures earlier this week.
When Ben Harder and his team of health analysts at U.S. News & World Report developed a suite of health equity measures for America’s hospitals, they expected to find some level of disparity, but nothing prepared them for the shocking magnitude of inequity they uncovered.
To comprehend the significance of disparities articulated in the U.S. News study and define the scorecards’ impact on bragging rights at cancer centers, The Cancer Letter asked four leaders in oncology to evaluate the health equity measures.
In 1993, when William Hait came to New Jersey to start work toward the NCI designation for Rutgers, the place had one office and three cubicles.
